SPRY
ARS Pharmaceuticals, Inc.
$9.07
-3.51%
2026-05-29
About ARS Pharmaceuticals, Inc.
ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions in the United States and internationally. The company is involved in the development of neffy, a needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. ARS Pharmaceuticals, Inc. was founded in 2015 and is headquartered in San Diego, California.
Key Fundamentals
Forward P/E
-11.97
EPS (TTM)
$-1.74
ROE
-92.3%
Revenue Growth (YoY)
-67.6%
Profit Margin
-203.3%
Debt/Equity
147.49
Price/Book
7.88
Beta
0.80
Market Cap
$900.2M
Avg Volume (10D)
1.8M
Recent Breakout Signals
No recent breakout signals detected for SPRY.
Recent Price Range (60 Days)
60D High
$9.87
60D Low
$7.03
Avg Volume
1.7M
Latest Close
$9.07
Get breakout alerts for SPRY
Sign up for Breakout Scanner to receive daily notifications when SPRY triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial.
ARS Pharmaceuticals, Inc. (SPRY) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors SPRY daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. SPRY operates in the Healthcare sector within the Biotechnology industry. Data is provided for informational purposes only and does not constitute financial advice.